US CGM Market
The United States Continuous Glucose Monitoring market analysis offered by DPI Research scrutinizes key growth factors that are impacting sales in the market. The report offers in-depth insights covering key factors such as drivers, opportunities, key players’ strategies, and demand outlook for the CGM market. In addition to this, the study analyzes latest trends across various segments including product type and end use.
Amid the COVID-19 crisis, the United States Continuous Glucose Monitoring (CGM) was valued at $2,830 Million in 2021 and is expected to grow at a CAGR of 11.5% in the forecast period, to reach $6,000 Million by 2028.
The Key Market Players for the United States Continuous Glucose Monitoring (CGM) Market are Listed Below: Abbott Dexcom, Inc. Medtronic, Inc. Senseonics Holdings, Inc.